Intercontinental Exchange insider sells 4,575 shares

Available on EDGAR 11/12/2026 - 04:30 PM EST Accepted by SEC EDGAR 11/12/2026 - 04:30 PM EST

(Neutral)

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Intercontinental Exchange, Inc. (ICE) General Counsel Andrew J. Surdykowski exercised 2,064 fully vested employee stock options on November 10, 2026, at a $57.31 exercise price, acquiring 2,064 common shares. He sold 4,575 common shares in three reported sales that day at per-share prices of $174.0421, $175.7410 and $176.2152. The acquisition and sales were effected under a Rule 10b5-1 trading plan approved and effective November 25, 2025. The reported option holding was zero after exercise.

Insider Trade Summary 10b5-1

Exercise and sale activity reported; no spread calculated

Exercise and Sale 5 txns

Insider Surdykowski Andrew J

Role General Counsel

Sold 4,575 shs ($801K)

Approx. gross sale proceeds $801K

Approx. exercise cost $118K

Type	Security	Shares	Price	Value
Exercise	Employee Stock Option (right to buy) Holding ^F8	2,064	$0.00	$0.00
Exercise	Common Stock ^F1	2,064	$57.31	$118K
Sale	Common Stock ^{F1, F2}	2,018	$174.0421	$351K
Sale	Common Stock ^{F1, F3}	2,000	$175.741	$351K
Sale	Common Stock ^{F1, F4, F5, F6, F7}	557	$176.2152	$98K

Holdings After Transaction: Employee Stock Option (right to buy) Holding — 0 options (Direct); Common Stock — 40,554 shares (Direct)

Footnotes (8)

F1. This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 25, 2025.
F2. The price range for the aggregate amount sold by the direct holder is $173.87 - $174.81. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
F3. The price range for the aggregate amount sold by the direct holder is $175.14 - $176.05. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
F4. The price range for the aggregate amount sold by the direct holder is $176.18 - $176.24. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
F5. The common stock number referred in Table I is an aggregate number and represents 33,380 shares of common stock and 5,734 unvested restricted stock units ("RSUs"), and 1,440 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
F6. The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.
F7. The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
F8. These options are fully vested.

Key Figures

Employee stock options exercised: 2,064 options Exercise price: $57.31 per share Common shares acquired: 2,064 shares +5 more

8 metrics

Employee stock options exercised 2,064 options November 10, 2026; the reported option holding was zero after exercise

Exercise price $57.31 per share For the 2,064 employee stock options exercised on November 10, 2026

Common shares acquired 2,064 shares Acquired upon option exercise on November 10, 2026

Common shares sold 4,575 shares Three reported sales on November 10, 2026, under a Rule 10b5-1 trading plan

Sale price $174.0421 per share 2,018 shares; reported price range $173.87–$174.81 on November 10, 2026

Sale price $175.7410 per share 2,000 shares; reported price range $175.14–$176.05 on November 10, 2026

Sale price $176.2152 per share 557 shares; reported price range $176.18–$176.24 on November 10, 2026

Reported option holding after exercise 0 options Following the November 10, 2026 exercise

Key Terms

Rule 10b5-1 trading plan, Employee Stock Option (right to buy)

2 terms

Rule 10b5-1 trading plan regulatory

"the acquisition and sales were effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

Employee Stock Option (right to buy) financial

"2,064 Employee Stock Option (right to buy) holdings exercised"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ICE shares did General Counsel Andrew J. Surdykowski sell on November 10, 2026?

Andrew J. Surdykowski sold 4,575 shares in three transactions: 2,018 at a reported $174.0421 per share (range $173.87–$174.81), 2,000 at $175.7410 (range $175.14–$176.05), and 557 at $176.2152 (range $176.18–$176.24). The sales were made under a Rule 10b5-1 trading plan approved and effective November 25, 2025.

How many ICE options did General Counsel Andrew J. Surdykowski exercise, and at what price?

He exercised 2,064 fully vested employee stock options on November 10, 2026, at an exercise price of $57.31 per share, acquiring 2,064 common shares. The reported option holding was zero after the exercise, and the options had an expiration date of January 18, 2027.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Surdykowski Andrew J

(Last)

(First)

(Middle)

5660 NEW NORTHSIDE DRIVE

(Street)

ATLANTA

GEORGIA

30328

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Intercontinental Exchange, Inc. [ ICE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	General Counsel

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	11/10/2026		M		2,064⁽¹⁾	A	$57.31	45,129	D
Common Stock	11/10/2026		S		2,018⁽¹⁾	D	$174.0421⁽²⁾	43,111	D
Common Stock	11/10/2026		S		2,000⁽¹⁾	D	$175.741⁽³⁾	41,111	D
Common Stock	11/10/2026		S		557⁽¹⁾	D	$176.2152⁽⁴⁾	40,554⁽⁵⁾⁽⁶⁾⁽⁷⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Employee Stock Option (right to buy) Holding	$57.31	11/10/2026		M			2,064	⁽⁸⁾	01/18/2027	Common Stock	2,064	$0	0	D

Explanation of Responses:

1. This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 25, 2025.

2. The price range for the aggregate amount sold by the direct holder is $173.87 - $174.81. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

3. The price range for the aggregate amount sold by the direct holder is $175.14 - $176.05. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

4. The price range for the aggregate amount sold by the direct holder is $176.18 - $176.24. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

5. The common stock number referred in Table I is an aggregate number and represents 33,380 shares of common stock and 5,734 unvested restricted stock units ("RSUs"), and 1,440 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.

6. The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.

7. The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.

8. These options are fully vested.

	/s/ Octavia N. Spencer, Attorney-in-fact	11/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR